Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1994-11-10
1995-11-14
Naff, David M.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
435 29, 435134, 435946, 4352571, C12Q 164, C12Q 102, C12P 764
Patent
active
054664349
ABSTRACT:
Labelled triglyceride oils are produced for use in diagnostic breath test. The process involves the cultivation of microorganisms capable of producing the oils in an appropriately controlled environment wherein the microorganisms are fed .sup.13 C or .sup.14 C labeled carbon substrates to induce the microorganisms to produce the labeled oils. The preferred labelled carbon substrate is a substrate containing .sup.13 C. The oil produced is preferrably enriched in oleic acid. The microorganisms can be induced to produce the oil by nitrogen depletion during cultivation.
REFERENCES:
patent: 3854240 (1974-12-01), Oldham et al.
patent: 4485173 (1984-11-01), Gierhart
Biological Abstracts, vol. 81, No. 4, (Feb. 15, 1986) Eicke, "The Present State of Bleaching in the Refining Process . . . " pp. 355-359.
Radioisotopy vol. No. 2, (1975) M. Matucha, "Higher Fatty Acids in Chlor. Yulgaris (Pyrenoidosa): Content Individual Acids and Use . . . " pp. 205-214.
"Proceedings-World Conference on Emerging Technologies in the Fats and Oil Industry . . . ", (1986) C. Ratledge, pp. 318-330.
Chem. Abstracts, vol. 95, No. 13 (1981), Butler et al., "Modification of the Carbon-14 . . . " p. 316 and abs. No. 111201X, 112(3), pp. 371-374.
Chem. Abstracts, vol. 87, No. 19 (1978), Watkins et al., "13C-trioctanoin: a nonradioactive . . ." pp. 261-262 and abs. No. 148249e 90(3), pp. 422-430.
Gladue et al., "Production of Eicosapentaenoic acid . . . " Proceedings of Sessions Lectures . . . vol. II (JOCS) (1988).
Caspary, Clin. Gastroenterol., 7:351-374 (1978).
Einarsson, et al., ".sup.14 C-Triolein Breath Test as a Rapid and Convenient Screening Test for Fat Malabsorption", (1982).
Korsten, et al., J. Lab. Clinl. Med., 109:62-66 (1987).
Watkins, et al., Gastroenterology, 82:911-7 (1982).
Clandinin, et al., Am. J. Clin. Nutr., 48:587-91 (1988).
Chen et al., ".sup.13 C-Labeled fatty acids from microalgae", Developments In Industrial Microbiology, vol. 31, pp. 257-264.
Heoksema et al., "An EPA-Containing Oil from Microalgae in Culture," Health Effects of Fish and Fish Oils, Chandra. ed., ARTS Biomedical Publishers, Newfoundland, 1989, pp. 337-347.
Journal of the American Medical Association, 247:1926 (1982).
Ben-Amotz, et al., J. Phycol., 21:72-81 (1985).
Tornabene et al., Enzyme Microb. Technol., 5:435-440 (1983).
Martek Corporation
Meller Mike
Naff David M.
LandOfFree
Method of diagnosing fatty acid metabolism or absorption disorde does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing fatty acid metabolism or absorption disorde, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing fatty acid metabolism or absorption disorde will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1219105